310 related articles for article (PubMed ID: 19834629)
1. Mycophenolate mofetil: An update.
Villarroel MC; Hidalgo M; Jimeno A
Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
4. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
6. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
Allison AC; Eugui EM
Transplantation; 2005 Oct; 80(2 Suppl):S181-90. PubMed ID: 16251851
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil--clinical and experimental experience.
Pirsch JD; Sollinger HW
Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of mycophenolate mofetil.
Allison AC
Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil.
Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
Yashima Y; Ohgane T
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
[TBL] [Abstract][Full Text] [Related]
13. From mice to man: the preclinical history of mycophenolate mofetil.
Sollinger HW
Clin Transplant; 1996 Feb; 10(1 Pt 2):85-92. PubMed ID: 8680054
[TBL] [Abstract][Full Text] [Related]
14. The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
Naesens M; de Loor H; Vanrenterghem Y; Kuypers DR
Transplantation; 2007 Aug; 84(3):362-73. PubMed ID: 17700162
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
Liang MZ; Lu YP; Nan F; Li YP
Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
Bullingham R; Monroe S; Nicholls A; Hale M
J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
[TBL] [Abstract][Full Text] [Related]
17. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in pediatric renal transplantation.
Weber LT; Höcker B; Mehls O; Tönshoff B
Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
Fulton B; Markham A
Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
